These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24074836)

  • 1. CD31 expression in plasmacytic/plasmablastic lesions.
    Plocharczyk E; Wakely PE
    Ann Diagn Pathol; 2013 Dec; 17(6):498-501. PubMed ID: 24074836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features of B-Cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases.
    Oliveira JL; Grogg KL; Macon WR; Dogan A; Feldman AL
    Am J Surg Pathol; 2012 Sep; 36(9):1364-70. PubMed ID: 22895269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ultrastructural features of plasmablastic lymphoma.
    Goedhals J; Beukes CA; Cooper S
    Ultrastruct Pathol; 2006; 30(6):427-33. PubMed ID: 17182435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade plasmablastic neoplasm of humerus in an HIV-negative patient, which was indeterminate between plasmablastic lymphoma and plasmablastic myeloma.
    Mondal SK; Bera H; Biswas PK; Mallick MG
    J Cancer Res Ther; 2011; 7(2):214-6. PubMed ID: 21768719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxiredoxin I is differentially expressed in multiple myelomas and in plasmablastic lymphomas.
    Demasi AP; Magalhães MH; Furuse C; Araújo NS; Junqueira JL; Araújo VC
    Oral Dis; 2008 Nov; 14(8):741-6. PubMed ID: 18565146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.
    Vega F; Chang CC; Medeiros LJ; Udden MM; Cho-Vega JH; Lau CC; Finch CJ; Vilchez RA; McGregor D; Jorgensen JL
    Mod Pathol; 2005 Jun; 18(6):806-15. PubMed ID: 15578069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.
    Colomo L; Loong F; Rives S; Pittaluga S; Martínez A; López-Guillermo A; Ojanguren J; Romagosa V; Jaffe ES; Campo E
    Am J Surg Pathol; 2004 Jun; 28(6):736-47. PubMed ID: 15166665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual case of plasmablastic non-Hodgkin's lymphoma located in the liver. First case reported in an AIDS patient.
    Metta H; Corti M; Maranzana A; Schtirbu R; Narbaitz M; De Dios Soler M
    Ann Hepatol; 2009; 8(3):242-5. PubMed ID: 19841505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse large B-cell lymphomas with plasmablastic differentiation.
    Teruya-Feldstein J
    Curr Oncol Rep; 2005 Sep; 7(5):357-63. PubMed ID: 16091196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous localization of plasmablastic multiple myeloma with heterotopic expression of CD3 and CD4: Skin involvement revealing systemic disease.
    Varricchio S; Pagliuca F; Travaglino A; Gallo L; Villa MR; Mascolo M
    J Cutan Pathol; 2019 Aug; 46(8):619-622. PubMed ID: 31025408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLI-1 is expressed in a wide variety of hematolymphoid neoplasms: a special concern in the differential diagnosis.
    Cho U; Cha HJ; Kim HJ; Min SK; Kim HK; Jung HR; Park G; Kim JE
    Clin Exp Med; 2024 Jan; 24(1):18. PubMed ID: 38280044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
    Qi CF; Zhou JX; Lee CH; Naghashfar Z; Xiang S; Kovalchuk AL; Fredrickson TN; Hartley JW; Roopenian DC; Davidson WF; Janz S; Morse HC
    Cancer Res; 2007 Mar; 67(6):2439-47. PubMed ID: 17363561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
    Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
    Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmablastic lymphomas with light chain restriction - plasmablastic extramedullary plasmacytomas?
    Boy SC; van Heerden MB; Raubenheimer EJ; van Heerden WF
    J Oral Pathol Med; 2010 May; 39(5):435-9. PubMed ID: 20537055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors.
    Guedez L; Martinez A; Zhao S; Vivero A; Pittaluga S; Stetler-Stevenson M; Raffeld M; Stetler-Stevenson WG
    Blood; 2005 Feb; 105(4):1660-8. PubMed ID: 15479729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.
    Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F
    Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human myeloma cells express the CD38 ligand CD31.
    Vallario A; Chilosi M; Adami F; Montagna L; Deaglio S; Malavasi F; Caligaris-Cappio F
    Br J Haematol; 1999 May; 105(2):441-4. PubMed ID: 10233418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between intracranial plasmacytoma and multiple myeloma: clinicopathological outcome study.
    Schwartz TH; Rhiew R; Isaacson SR; Orazi A; Bruce JN
    Neurosurgery; 2001 Nov; 49(5):1039-44; discussion 1044-5. PubMed ID: 11846895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of plasma cell morphology in multiple myeloma.
    Paule B; Quillard J; Bisson M; Kahn MF; Massias P
    Nouv Rev Fr Hematol (1978); 1988; 30(4):209-12. PubMed ID: 3194186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
    Morley AM; Verity DH; Meligonis G; Rose GE
    Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.